Find Your MAC! Add TransLabs as a preferred
source on Google
Prior Auth Denial Data

Public Prior Auth Denial Data: How Labs Can Use It to Prioritize High-Value Payers

Under the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), Medicare Advantage organizations, state Medicaid and CHIP programs, Medicaid managed care plans, CHIP managed care entities, and QHP issuers on the federal exchanges must post prior authorization metrics on their websites every year. The first reports were due March 31, 2026. They show approval and denial rates, approvals after appeal, extended reviews, and average and median decision times. Labs can combine this public data with their own revenue and denial history to score each payer and decide where to spend denial management, appeals, and contracting effort first. The data is aggregated across all services, not lab-specific, so it works best as a starting signal, not a final answer.

Key Takeaways

  • It’s public now: impacted payers must post prior auth metrics yearly, starting March 31, 2026.
  • What’s in it: approval and denial rates, approvals after appeal, extended reviews, and average and median decision times for standard and expedited requests.
  • What’s not: test-level or lab-specific results. The numbers cover all items and services except drugs.
  • Pair it with your own data: public metrics show payer behavior; your claims show what it costs you.
  • Score, don’t guess: a simple weighted score turns five data points into a clear priority order.
  • Match the play to the payer: some payers need front-end fixes, some need appeals, and some need escalation.

For years, labs had to guess how tough each payer was on prior authorization. You knew which plans felt painful. You just couldn’t prove it, or compare them on equal terms.

That changed in 2026. Federal rules now make most government-backed health plans publish their prior auth numbers. For a lab juggling dozens of payers and a limited billing team with no reliable lab RCM services, that data is a gift, if you know how to read it.

What payer prior auth data is now public?

The requirement comes from CMS-0057-F, the CMS Interoperability and Prior Authorization Final Rule. Impacted payers must post the following metrics on their public websites once a year:

MetricWhat it tells a lab
List of all items and services that require prior authorizationWhich of your tests are exposed with each payer
% of standard requests approvedBaseline friction for routine requests
% of standard requests deniedHow often requests fail on the first pass
% of standard requests approved after appealHow often a denial turns out to be wrong
% of requests with an extended review that were approvedHow often payers stall before saying yes
% of expedited requests approved and deniedHow the payer handles urgent cases
Average and median time to decision (standard and expedited)Cash flow drag and turnaround risk

Which payers have to publish?

Payer typeReporting level
Medicare Advantage organizationsOrganization level
State Medicaid and CHIP fee-for-service programsState level
Medicaid managed care plans and CHIP managed care entitiesPlan level
QHP issuers on the Federally-facilitated ExchangesIssuer level

Original Medicare and most employer-sponsored plans aren’t covered. So the public data won’t help you rank every commercial payer, but it does cover a big share of the lab prior auth that hurts most.

There’s also outside research worth reading. KFF’s analyses of Medicare Advantage prior authorization have found that only a small share of denials get appealed, yet most appealed denials are overturned. That gap is the opportunity this article is about.

Want to know which payers are costing your lab the most? Ask TransLabs.

The limits: read the data with care

LimitationHow to work around it
Metrics are aggregated across all services, not lab-specificUse them to compare payers, then confirm with your own lab claims
Large MA organizations report at the organization levelMap your lab’s plans to the right parent organization
Data lags by a yearPair it with your last 90 days of remits
Lab benefit managers aren’t broken outAsk each plan who runs lab prior auth and track that vendor separately
Formats differ by payerBuild one standard intake sheet and normalize everything into it

How labs can use the data: a five-step method

How labs can use the data a five-step method

Step 1: Find each payer’s report

Each payer posts its own report, usually on a page about prior authorization or interoperability. Start with your top 15 payers by revenue in Medicare Advantage, Medicaid managed care, and exchange plans.

Step 2: Pull the core metrics

Capture standard denial rate, approved after appeal, median decision time, and the list of services needing prior auth. Note whether your highest-volume prior auth tests, often molecular, genetic, and specialty panels, appear on that list.

Step 3: Match it with your own data

Pull 12 months of remits by payer. Track prior auth denials using CARC 197 (authorization absent), CARC 15 (authorization number missing or invalid), and CARC 198 (authorization exceeded), along with any RARCs that come with them. Add revenue at stake and your own appeal win rate.

Step 4: Score each payer

Score each factor from 1 to 5, then weight it. Here’s a simple model you can adjust:
FactorWeightScoring logic (5 = highest priority)
Lab revenue at stake35%Higher revenue scores higher
Public denial rate20%Higher denial rate scores higher
Approved after appeal15%Higher overturns mean more winnable dollars
Median decision time10%Slower decisions mean more cash drag
Your lab’s prior auth denial rate20%Higher internal denials score higher

Step 5: Act on the results

Rank the scores and assign each payer a play. Don’t spread effort evenly. The top two or three payers usually hold most of the recoverable revenue.

Worked example: four payers, one priority list

This illustrative outreach lab compares four anonymized payers. All figures are examples, not real payer results.
PayerRevenue (score)Public denial (score)Approved after appeal (score)Median days (score)Lab PA denial (score)Priority score
Payer A (MA plan)$820k (5)9.5% (3)4.2% (5)5 (3)12% (4)4.20
Payer B (Medicaid MCO)$410k (3)14.0% (5)1.1% (1)7 (5)18% (5)3.70
Payer D (Exchange QHP)$190k (1)11.5% (4)3.6% (4)6 (4)9% (3)2.75
Payer C (MA plan)$560k (4)4.0% (1)0.8% (1)2 (1)3% (1)2.05
Worked example four payers, one priority list
Payer A tops the list. It’s the biggest revenue source, and its denials often get overturned on appeal, so a structured appeal program pays off fast. Payer B scores high too, but appeals rarely win there. That points to front-end fixes and escalation through provider relations, not more appeals. Payer C is large but low friction, so it just needs monitoring.

Match the play to the payer

QuadrantSignalBest play
Fight & fixHigh denials, high appeal successBuild appeal templates by test; fix the documentation gaps behind repeat denials
EscalateHigh denials, low appeal successMeet with provider relations; challenge policy criteria; review contract terms
WatchLow denials, high appeal successSpot-check denials; appeal the outliers
MaintainLow denials, low appealsKeep eligibility and prior auth checks tight; review yearly

Using the data in payer conversations

Public metrics change the tone of a provider relations meeting. Instead of “we feel like you deny a lot,” you can say “your published denial rate is well above your peers, and our appeal win rate with you suggests many of those denials don’t hold up.” Bring your own CARC trends, and the conversation moves from complaint to evidence.
Ready to turn payer data into recovered revenue? Talk to TransLabs.

Frequently Asked Questions

Where can I find payer prior authorization denial data?

Impacted payers post it on their own public websites, usually on a prior authorization or interoperability page. Reports are updated annually.
The first reports under CMS-0057-F were due by March 31, 2026, covering the prior calendar year.
No. Metrics are aggregated across all items and services except drugs. Labs should combine them with their own claims data.
Common ones include CARC 197 (authorization absent), CARC 15 (authorization number missing or invalid), and CARC 198 (authorization exceeded).
Most don’t. The rule covers Medicare Advantage, Medicaid, CHIP, and QHP issuers on the federal exchanges.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!